Almac’s Clinical Services business unit has expanded its service offering for dispensing and bottling solid dosage products.
Managing director of Almac Clinical Services, Dr Robert Dunlop commented: “In recent years we have experienced an increase in demand for facilities equipped to handle compounds of a higher potency. As a customer-orientated company Almac saw an opportunity to meet the needs of its client base.”
“This development at our European and North American Headquarters is the latest example of how Almac constantly strives to advance its service offering to reflect the needs of the drug development industry,” he concluded.
Following successful installation and validation, the facilities are now operational and Almac welcome packaging discussions with companies who have potent products in their pipeline.
